1. Incidence, therapy, and outcome in the management of chronic subdural hematoma in Switzerland: a population-based multicenter cohort study
- Author
-
Amir El Rahal, Jürgen Beck, Peter Ahlborn, Corrado Bernasconi, Serge Marbacher, Stefan Wanderer, Jan-Karl Burkhardt, Roy Thomas Daniel, Andrea Ferrari, Oliver Hausmann, Maria Kamenova, Karl Kothbauer, Katharina Lutz, Luigi Mariani, Alex Alfieri, Daniel Schöni, Philippe Schucht, Andreas Raabe, Luca Regli, Dominique Kuhlen, Martin Seule, Jehuda Soleman, Daniele Starnoni, Julien Zaldivar, Christian Zweifel, Karl Schaller, and Christian Fung
- Subjects
neurosurgery ,cSDH ,chronic subdural hematoma ,incidence ,therapy ,outcome ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
BackgroundChronic subdural hematoma (cSDH) is a disease affecting mainly elderly individuals. The reported incidence ranges from 2.0/100,000 to 58 per 100,000 person-years when only considering patients who are over 70 years old, with an overall incidence of 8.2–14.0 per 100,000 persons. Due to an estimated doubling of the population above 65 years old between 2000 and 2030, cSDH will become an even more significant concern. To gain an overview of cSDH hospital admission rates, treatment, and outcome, we performed this multicenter national cohort study of patients requiring surgical treatment of cSDH.MethodsA multicenter cohort study included patients treated in 2013 in a Swiss center accredited for residency. Demographics, medical history, symptoms, and medication were recorded. Imaging at admission was evaluated, and therapy was divided into burr hole craniostomy (BHC), twist drill craniostomy (TDC), and craniotomy. Patients' outcomes were dichotomized into good (mRS, 0–3) and poor (mRS, 4–6) outcomes. A two-sided t-test for unpaired variables was performed, while a chi-square test was performed for categorical variables, and a p-value of
- Published
- 2023
- Full Text
- View/download PDF